GSTC
GlobeStar Therapeutics.

991
Mkt Cap
$1,241.00
Volume
400.00
52W High
$0.0003
52W Low
$0.00
Price
$0.00
GSTC Fundamentals
50D MA
$0.00
Beta
-20.73
Avg. Volume
610,412.73
Loading...
Loading...
GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company was founded by David P. Summers in 2011 and is headquartered in Richland, WA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of GlobeStar Therapeutics Corp?
What is the 52-week high for GlobeStar Therapeutics Corp?
What is the 52-week low for GlobeStar Therapeutics Corp?
What is the 50-day moving average of GlobeStar Therapeutics Corp?

Latest GSTC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.